Enterosys is a biotech compagny specialized in high-quality preclinical evaluation services.
Our team of physiologists and pharmacologists offers a unique platform with a wide range of in vitro and in vivo assays.
Founded in 2017, Enterosys has developed its own R&D projects (or pipeline) in addition to its partnering expertise in preclinical research.
Our corporate culture is driven by the flexibility, responsiveness and quality of our interactions with our customers.
We conduct studies using validated GLP-like protocols and project management methods
We foster in-depth scientific discussions focused on understanding customers needs and offering tailor-made solutions
We strive to deliver the best results, regardless of the magnitude of the challenge